Assessment of Patients Treated With JETREA® for Vitreomacular Traction

Status:
Completed

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

The purpose of this study is to observe the anatomical and functional outcomes of ocriplasmin (JETREA®) over a 6-month follow-up period.

Phase 4

Alcon Research